| Literature DB >> 22363335 |
Scott R Clingenpeel1, Jaina L Moan, Danielle M McGrath, Bruce A Hungate, Mary E Watwood.
Abstract
One difficulty in using bioremediation at a contaminated site is demonstrating that biodegradation is actually occurring in situ. The stable isotope composition of contaminants may help with this, since they can serve as an indicator of biological activity. To use this approach it is necessary to establish how a particular biodegradation pathway affects the isotopic composition of a contaminant. This study examined bacterial strains expressing three aerobic enzymes for their effect on the (13)C/(12)C ratio when degrading both trichloroethene (TCE) and cis-1,2-dichloroethene (c-DCE): toluene 3-monoxygenase, toluene 4-monooxygenase, and toluene 2,3-dioxygenase. We found no significant differences in fractionation among the three enzymes for either compound. Aerobic degradation of c-DCE occurred with low fractionation producing δ(13)C enrichment factors of -0.9 ± 0.5 to -1.2 ± 0.5, in contrast to reported anaerobic degradation δ(13)C enrichment factors of -14.1 to -20.4‰. Aerobic degradation of TCE resulted in δ(13)C enrichment factors of -11.6 ± 4.1 to -14.7 ± 3.0‰ which overlap reported δ(13)C enrichment factors for anaerobic TCE degradation of -2.5 to -13.8‰. The data from this study suggest that stable isotopes could serve as a diagnostic for detecting aerobic biodegradation of TCE by toluene oxygenases at contaminated sites.Entities:
Keywords: aerobic biodegradation; cis-1,2-dichloroethene; stable carbon isotope; toluene oxygenase; trichloroethene
Year: 2012 PMID: 22363335 PMCID: PMC3282480 DOI: 10.3389/fmicb.2012.00063
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Degradation curves of . Each point is the average of five samples and the error bars indicate 1 SD.
Degradation rates over the first 12 h ± 1 SD for .
| Strain | Pathway | mg CE/mg cell dry mass day | |
|---|---|---|---|
| c-DCE | TCE | ||
| F1 | TDO | 0.067 ± 0.021 | 0.035 ± 0.017 |
| CFS215 | TDO | 0.038 ± 0.015 | 0.031 ± 0.014 |
| PKO1 | T3MO | 0.053 ± 0.028 | 0.034 ± 0.017 |
| KR1 | T4MO | 0.343 ± 0.111 | 0.098 ± 0.068 |
Figure 2Rayleigh plots of .
Enrichment factors (ε) expressed in ‰±1 SD for δ.
| Strain | Pathway | c-DCE | TCE |
|---|---|---|---|
| F1 | TDO | −1.10 ± 0.77 | −13.82 ± 1.55 |
| CFS215 | TDO | −1.23 ± 0.45 | −14.70 ± 3.02 |
| PKO1 | T3MO | −0.89 ± 0.51 | −11.60 ± 4.11 |
| KR1 | T4MO | ND | −14.40 ± 6.44 |
ND, not determined.
Enrichment factors (ε) expressed in for δ.
| Pathway | c-DCE | TCE |
|---|---|---|
| Anaerobic | −12.0 to −25.5 | −2.5 to −18.9 |
| sMMO | −0.4 ± 0.5 | −1.1 ± 0.3 |
| T2MO | −19.3 ± 1.8 | |
| T3MO | −0.89 ± 0.51 | −11.60 ± 4.11 |
| T4MO | −14.40 ± 6.44 | |
| TDO | −1.17 ± 0.60 | −14.31 ± 2.38 |
.
.
.
The entries for each pathway indicate the mean and 1 SD of the data except for the anaerobic process where the range of values reported in the literature is given.